A clinical observation of the treatment with Naoxintong capsule in the vascular cognitive impairment

Liu Hanxing,Zhang Junjian,Wang Qing
DOI: https://doi.org/10.3969/j.issn.1007-0478.2011.02.011
2011-01-01
Abstract:Objective To assess the efficacy and safety of Naoxintong capsule in vascular cognitive impairment(VCI).Methods 241 patients with VCI were randomly divided into the treatment group [n=121,VCI without dementia(VCIND):45,vascular dementia(VaD):76] and the control group(n=120,VCIND:44,VaD:76).The cases of treatment group were treated with Naoxintong capsule(4 tables Tid) and the control group were treated with Dan-shen(4 tables Tid).The duration of therapy was three months.MMSE and ADL were used to evaluate outcome.Results The scores of both MMSE and ADL were higher in the VCIND treatment group.In the VaD treatment group,the scores of ADL but not MMSE indicated clinical improvement significantly.Conclusions Naoxintong may improve cognitive function in patient with VCIND.
What problem does this paper attempt to address?